Skip to Main Content

Author Details

Kim-Hien T Dao
Astex Pharmaceuticals
2009
26
15
PMIDPaper TitleJournal TitlePublished Year
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
32358832A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option.Transfusion2020
31844143Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.Leukemia2020
31880950Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.J Clin Oncol2020
30836091Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged â¿¥70 years.Hematol Oncol Stem Cell Ther2019
31366621Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.Blood2019
30559310Two myeloid leukemia cases with rare <i>FLT3</i> fusions.Cold Spring Harb Mol Case Stud2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
28983816Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.Curr Hematol Malig Rep2017
28189174Myelodysplastic Syndromes: Updates and Nuances.Med Clin North Am2017
28095380Polycythemia Vera Management and Challenges in the Community Health Setting.Oncology2017
26752680A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia.Leuk Lymphoma2016
26573090Mutant calreticulin-expressing cells induce monocyte hyperreactivity through a paracrine mechanism.Am J Hematol2016
26648538Age-related mutations and chronic myelomonocytic leukemia.Leukemia2016
27235757Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.Exp Hematol2016
26870618Durable Disease Control with MEK Inhibition in a Patient with NRAS-mutated Atypical Chronic Myeloid Leukemia.Cureus2015
26637732What's different about atypical CML and chronic neutrophilic leukemia?Hematology Am Soc Hematol Educ Program2015
25180155Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia.Leuk Res Rep2014
23275297ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.Proc Natl Acad Sci U S A2013
23783032The PI3K/Akt1 pathway enhances steady-state levels of FANCL.Mol Biol Cell2013
23382113Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.Clin Cancer Res2013
23333150A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition.Cell Stem Cell2013
22653977FANCL ubiquitinates β-catenin and enhances its nuclear function.Blood2012
20067638Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts.BMC Cancer2010
20519627BCR-ABL SH3-SH2 domain mutations in chronic myeloid leukemia patients on imatinib.Blood2010
19237556Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation.Proc Natl Acad Sci U S A2009
  • 1 - 26 of 26

Recommended Authors

Bartlomiej Przychodzen
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 2
Anagha Deshpande
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 16
Felicitas Thol
Hannover Medical School
Career Start Year 2007
Number of shared co-authors 8
Paulo Vidal Campregher
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 0
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 3
Rashmi Kanagal-Shamanna
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Yana Pikman
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 6
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 2
Jean-Baptiste Micol
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 4
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Career Start Year 2004
Number of shared co-authors 2
Anna L Brown
Adelaide Medical School, University of Adelaide
Career Start Year 2003
Number of shared co-authors 5
Thomas Ernst
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 4
Guang Fan
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 44
Jeffery M Klco
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 2
Lukas D Wartman
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 2
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 12
Angela G Fleischman
University of California Irvine
Career Start Year 1998
Number of shared co-authors 25
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 3
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 34
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 7
Matthew J Walter
Washington University School of Medicine in St. Louis
Career Start Year 1994
Number of shared co-authors 7
Lucy A Godley
The University of Chicago
Career Start Year 1994
Number of shared co-authors 9
Seishi Ogawa
Kyoto University
Career Start Year 1993
Number of shared co-authors 5
Timothy A Graubert
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 7
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 10
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 26
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 4
Derek L Stirewalt
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 15
Jerald P Radich
Fred Hutchinson Cancer Center
Career Start Year 1989
Number of shared co-authors 33

Collaborators

Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Co-authored papers 14
Brian J Druker
Oregon Health & Science University
Co-authored papers 12
Michael W Deininger
University of Utah Huntsman Cancer Institute
Co-authored papers 7
Jason Gotlib
Stanford University School of Medicine
Co-authored papers 6
Richard D Press
Oregon Health and Science University
Co-authored papers 6
Cristina E Tognon
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
Nicola Long
Oregon Health and Science University
Co-authored papers 4
Samantha L Savage
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Christopher A Eide
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Hyunjung Lee
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 4
Robert H Collins
University of Texas Southwestern Medical Center
Co-authored papers 4
Haijiao Zhang
Oregon Health & Science University, Knight Cancer Institute
Co-authored papers 4
Elie Traer
Oregon Health & Science University
Co-authored papers 4
Jessica Leonard
Oregon Health & Science University
Co-authored papers 3
Tara A Macey
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Angela Rofelty
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Daniel Bottomly
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Motomi Mori
St Jude Children's Research Hospital.
Co-authored papers 3
Amy Carlos
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Jennifer Dunlap
Oregon Health & Science University
Co-authored papers 3
Brian Junio
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Beth Wilmot
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 3
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 3
Chenwei Lin
Clinical Research Division, Fred Hutchinson Cancer Center
Co-authored papers 3
Rachel Henson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Uma Borate
The Ohio State University
Co-authored papers 3
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 3
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Release 1.2